A randomized, double-blind, multi-center, placebo-controlled, Phase 2 clinical trial to evaluate the efficacy and safety of DWJ211 in the treatment of moderate to severe submental fat

MLA

Seung Hwan, Paik, et al. “A Randomized, Double-Blind, Multi-Center, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of DWJ211 in the Treatment of Moderate to Severe Submental Fat.” Dermatologic TherapyREFERENCES, vol. 35, no. 5, Jan. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........42b1f5d6d1fd88ca2632d16e51427961&authtype=sso&custid=ns315887.

APA

Seung Hwan, P., Joon Min, J., Chang Jin, J., Hee Joo, Y., Hyung Seok, S., Sun Hye, S., Kwang Ho, Y., Yang Won, L., Beom Joon, K., & Chong Hyun, W. (2022). A randomized, double-blind, multi-center, placebo-controlled, Phase 2 clinical trial to evaluate the efficacy and safety of DWJ211 in the treatment of moderate to severe submental fat. Dermatologic TherapyREFERENCES, 35(5).

Chicago

Seung Hwan, Paik, Jung Joon Min, Jung Chang Jin, Yang Hee Joo, Son Hyung Seok, Shin Sun Hye, Yoo Kwang Ho, Lee Yang Won, Kim Beom Joon, and Won Chong Hyun. 2022. “A Randomized, Double-Blind, Multi-Center, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of DWJ211 in the Treatment of Moderate to Severe Submental Fat.” Dermatologic TherapyREFERENCES 35 (5). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........42b1f5d6d1fd88ca2632d16e51427961&authtype=sso&custid=ns315887.